The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), a joint Liberia-United States research partnership, has launched a clinical study in Liberia to evaluate a candidate Lassa fever vaccine.
According to Joseph Boye Cooper, one of the focal persons on the study, the research being conducted is in collaboration with IAVI, a nonprofit scientific research organization and the study sponsor, is seeking to recruit 60 healthy adult volunteers at PREVAIL Redemption Hospital site in Montserrado County.
